The Home Sweet Home study.

The Home Sweet Home study: An observational, longitudinal study on the home environment of people with chronic obstructive pulmonary disease (COPD).

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24106

Enrollment

384

Registered

2013-04-08

Start date

2013-05-01

Completion date

Unknown

Last updated

2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with Chronic Obstructive Pulmonary Disease (COPD) + their resident loved ones.

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. COPD as main diagnosis (GOLD stage II, III or IV according to GOLD guidelines); 2. No exacerbation or hospitalization <4 weeks before enrolment; 3. Providing written informed consent; 4. One resident loved one also provided a written informed consent to participate.

Exclusion criteria

Exclusion criteria: 1. Unable to complete the study questionnaires because of cognitive impairment as determined by the ‘Short Blessed Test’, for both the patient as well as the loved one; 2. Unable to speak or understand Dutch, for both the patient as well as the loved one.

Design outcomes

Primary

Measure	Time frame
The resident loved one, their perception of the person with COPD, and the person with COPD will be compared by using the: 1. Problematic ADLs using the Canadian Occupational Performance Measure (COPM); 2. COPD Assessment Test (CAT); 3. mMRC dyspnea scale; 4. Short-Form 12; 5. Instrumental Activities of Daily Living Scale (IADLS); 6. EQ-5D; 7. Fatigue using the Subjective Fatigue subscale of the Checklist Individual Strength; 8. Self-efficacy for home walking.	—

Measure

Time frame

The resident loved one, their perception of the person with COPD, and the person with COPD will be compared by using the: 1. Problematic ADLs using the Canadian Occupational Performance Measure (COPM); 2. COPD Assessment Test (CAT); 3. mMRC dyspnea scale; 4. Short-Form 12; 5. Instrumental Activities of Daily Living Scale (IADLS); 6. EQ-5D; 7. Fatigue using the Subjective Fatigue subscale of the Checklist Individual Strength; 8. Self-efficacy for home walking.

—

Secondary

Measure	Time frame
The secondary study parameters will be: 1. Hospital Anxiety and Depression scale (HADS); 2. Care Dependency Scale (CDS); 3. Daily symptoms checklist; 4. Current smoking status and smoking history; 5. Fat-free mass (using BIA), body weight and height; 6. Physical activity (using validated accelerometer); 7. Informal and professional (medical) care <6 months; 8. Perceived social support using the Medical Outcome Study Social Support Survey (MOSSSS); 9. Post-bronchodilator spirometry; 10. Blood pressure, heart rate and oxygen saturation at rest; 11. Timed-up-and-go test; 12. Utrecht Coping List; 13. Caregiver burden and positive aspects of caregiving using the FACQ-PC; 14. A 35-item COPD knowledge questionnaire (self-developed, currently tested); 15. Dutch relationship questionnaire 2003 (Uitgever: Pearson Assessment and Information B.V.). Other study parameters will be: 16. Demographics, including marital status; 17. Data on relationship of the loved one to the patient; 18. Medical history; 19. Current medication; 20. Charlson co-morbidity index.	—

Measure

Time frame

The secondary study parameters will be: 1. Hospital Anxiety and Depression scale (HADS); 2. Care Dependency Scale (CDS); 3. Daily symptoms checklist; 4. Current smoking status and smoking history; 5. Fat-free mass (using BIA), body weight and height; 6. Physical activity (using validated accelerometer); 7. Informal and professional (medical) care <6 months; 8. Perceived social support using the Medical Outcome Study Social Support Survey (MOSSSS); 9. Post-bronchodilator spirometry; 10. Blood pressure, heart rate and oxygen saturation at rest; 11. Timed-up-and-go test; 12. Utrecht Coping List; 13. Caregiver burden and positive aspects of caregiving using the FACQ-PC; 14. A 35-item COPD knowledge questionnaire (self-developed, currently tested); 15. Dutch relationship questionnaire 2003 (Uitgever: Pearson Assessment and Information B.V.). Other study parameters will be: 16. Demographics, including marital status; 17. Data on relationship of the loved one to the patient; 18. Medical history; 19. Current medication; 20. Charlson co-morbidity index.

—

Contacts

Public ContactMartijn A. Spruit

Program Development Centre CIRO+, centre of expertise for chronic organ failure Hornerheide 1

martijnspruit@ciro-horn.nl+31 (0)475 587726

Outcome results